Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Delbrück H[au]:

Search results

Items: 1 to 50 of 68

1.

[Clubfoot treatment through the ages: the Ponseti method in comparison to other conservative approaches and operative procedures].

Delbrück H, Schaltenbrand M, Schröder S, Rauschmann M, Schwenninger C.

Orthopade. 2013 Jun;42(6):427-33. doi: 10.1007/s00132-012-1989-5. German.

PMID:
23685498
2.

Contrast-enhanced MRI predicts local recurrence of osteoid osteoma after radiofrequency ablation.

Mahnken AH, Bruners P, Delbrück H, Günther RW, Plumhans C.

J Med Imaging Radiat Oncol. 2012 Dec;56(6):617-21. doi: 10.1111/j.1754-9485.2012.02443.x. Epub 2012 Sep 5.

PMID:
23210580
3.

GES-18, a new carbapenem-hydrolyzing GES-Type β-lactamase from Pseudomonas aeruginosa that contains Ile80 and Ser170 residues.

Bebrone C, Bogaerts P, Delbrück H, Bennink S, Kupper MB, Rezende de Castro R, Glupczynski Y, Hoffmann KM.

Antimicrob Agents Chemother. 2013 Jan;57(1):396-401. doi: 10.1128/AAC.01784-12. Epub 2012 Oct 31.

4.

Short-chain fluorescent tryptophan tags for on-line detection of functional recombinant proteins.

Siepert EM, Gartz E, Tur MK, Delbrück H, Barth S, Büchs J.

BMC Biotechnol. 2012 Sep 21;12:65. doi: 10.1186/1472-6750-12-65.

5.

Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 β-lactamases.

Delbrück H, Bogaerts P, Kupper MB, Rezende de Castro R, Bennink S, Glupczynski Y, Galleni M, Hoffmann KM, Bebrone C.

Antimicrob Agents Chemother. 2012 Nov;56(11):5618-25. doi: 10.1128/AAC.01272-12. Epub 2012 Aug 20.

6.

[Physical activity and tumor diseases].

Delbrück H.

Internist (Berl). 2012 Jun;53(6):688-97. doi: 10.1007/s00108-011-2934-0. German.

PMID:
22584271
7.

Affinity purification of a framework 1 engineered mouse/human chimeric IgA2 antibody from tobacco.

Boes A, Spiegel H, Delbrück H, Fischer R, Schillberg S, Sack M.

Biotechnol Bioeng. 2011 Dec;108(12):2804-14. doi: 10.1002/bit.23262. Epub 2011 Jul 19.

PMID:
21755499
8.

Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-beta-lactamases.

Lassaux P, Hamel M, Gulea M, Delbrück H, Mercuri PS, Horsfall L, Dehareng D, Kupper M, Frère JM, Hoffmann K, Galleni M, Bebrone C.

J Med Chem. 2010 Jul 8;53(13):4862-76. doi: 10.1021/jm100213c.

PMID:
20527888
9.

Radiofrequency ablation of osteoid osteoma: initial experience with a new monopolar ablation device.

Mahnken AH, Bruners P, Delbrück H, Günther RW.

Cardiovasc Intervent Radiol. 2011 Jun;34(3):579-84. doi: 10.1007/s00270-010-9891-1. Epub 2010 May 19.

PMID:
20490491
10.

[Corrective growth after vertebral body fracture in the adolescence].

Schmidt-Rohlfing B, Nossek M, Hofman M, Delbrück H, Hohl C.

Z Orthop Unfall. 2009 Sep-Oct;147(5):593-6. doi: 10.1055/s-0029-1186020. German.

PMID:
19938356
11.

The structure of the dizinc subclass B2 metallo-beta-lactamase CphA reveals that the second inhibitory zinc ion binds in the histidine site.

Bebrone C, Delbrück H, Kupper MB, Schlömer P, Willmann C, Frère JM, Fischer R, Galleni M, Hoffmann KM.

Antimicrob Agents Chemother. 2009 Oct;53(10):4464-71. doi: 10.1128/AAC.00288-09. Epub 2009 Aug 3.

12.

[Aftercare and rehabilitation of HIV patients in Western Africa].

Koala S, Lamontagne B, Delbrück H.

Rehabilitation (Stuttg). 2007 Dec;46(6):363-9. doi: 10.1055/s-2007-985171. German.

PMID:
18188808
13.

[Bilateral fibula graft. Biological reconstruction following resection of malignant bone tumors].

Tunn PU, Moesta TK, Delbrück H.

Chirurg. 2006 Oct;77(10):919-25. German.

PMID:
16855825
14.

Recombinant bovine uteroglobin at 1.6 A resolution: a preliminary X-ray crystallographic analysis.

von der Decken V, Delbrück H, Herrler A, Beier HM, Fischer R, Hoffmann KM.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 May 1;61(Pt 5):499-502. Epub 2005 Apr 22.

15.

Structure of palmitoylated BET3: insights into TRAPP complex assembly and membrane localization.

Turnbull AP, Kümmel D, Prinz B, Holz C, Schultchen J, Lang C, Niesen FH, Hofmann KP, Delbrück H, Behlke J, Müller EC, Jarosch E, Sommer T, Heinemann U.

EMBO J. 2005 Mar 9;24(5):875-84. Epub 2005 Feb 3.

16.

X-ray structure of fumarylacetoacetate hydrolase family member Homo sapiens FLJ36880.

Manjasetty BA, Niesen FH, Delbrück H, Götz F, Sievert V, Büssow K, Behlke J, Heinemann U.

Biol Chem. 2004 Oct;385(10):935-42.

PMID:
15551868
17.

Crystal structure of Homo sapiens protein hp14.5.

Manjasetty BA, Delbrück H, Pham DT, Mueller U, Fieber-Erdmann M, Scheich C, Sievert V, Büssow K, Niesen FH, Weihofen W, Loll B, Saenger W, Heinemann U.

Proteins. 2004 Mar 1;54(4):797-800. No abstract available. Erratum in: Proteins. 2004 May 15;55(3):783. Neisen, Frank H [corrected to Niesen, Frank H].

PMID:
14997576
18.

X-ray structure of human gankyrin, the product of a gene linked to hepatocellular carcinoma.

Manjasetty BA, Quedenau C, Sievert V, Büssow K, Niesen F, Delbrück H, Heinemann U.

Proteins. 2004 Apr 1;55(1):214-7. No abstract available.

PMID:
14997555
19.

[Ablative procedures in surgical treatment of malignant bone tumors].

Tunn PU, Delbrück H, Schlag PM.

Orthopade. 2003 Nov;32(11):955-64. German.

PMID:
14615845
20.

Crystal structures of mutant forms of the Bacillus caldolyticus cold shock protein differing in thermal stability.

Delbrück H, Mueller U, Perl D, Schmid FX, Heinemann U.

J Mol Biol. 2001 Oct 19;313(2):359-69.

PMID:
11800562
21.

An Src homology 3-like domain is responsible for dimerization of the repressor protein KorB encoded by the promiscuous IncP plasmid RP4.

Delbrück H, Ziegelin G, Lanka E, Heinemann U.

J Biol Chem. 2002 Feb 8;277(6):4191-8. Epub 2001 Nov 15.

22.
23.
24.
25.

[Value of tumor-associated antigens CA 72-4 vs. CEA and CA 19-9 in the follow-up after stomach cancer].

Gärtner U, Scheulen ME, Conradt C, Wiefelspütz J, Kruck P, Aghabi E, Delbrück H.

Dtsch Med Wochenschr. 1998 Jan 23;123(4):69-73. German.

PMID:
9487285
26.

[Assessment of work capacity and occupational rehabilitation in curatively treated tumor patients].

Delbrück H.

Versicherungsmedizin. 1997 Oct 1;49(5):167-72. Review. German.

PMID:
9417743
27.
28.

[Subjective discomfort of stomach cancer and esophageal cancer patients in after-care].

Delbrück H, Aghabi E.

Rehabilitation (Stuttg). 1993 Nov;32(4):232-5. German.

PMID:
8310174
29.

[The objectives, failures and new ways in hospital aftercare and rehabilitation].

Delbrück H.

Strahlenther Onkol. 1992 Nov;168(11):628-32. German.

PMID:
1333644
30.

[Postgastrectomy findings in the after care of 227 patients with stomach carcinoma].

Delbrück H, Severin M, Jansen G.

Z Gastroenterol. 1991 May;29(5):222-6. German.

PMID:
1950029
31.

[Sensitivity and specificity of CEA, Ca 15-3 and MCA levels in visceral breast carcinoma metastasis].

Delbrück H, Hagen-Aukamp C, Braun G.

Strahlenther Onkol. 1990 Jul;166(7):457-9. German.

PMID:
2200152
32.
33.

[Tasks and aims of the after care of cancer patients in the hospital].

Delbrück H.

Dtsch Krankenpflegez. 1989 Sep;42(9):601-4. German. No abstract available.

PMID:
2561884
34.
35.

[Prognosis, work and earning ability in "healed" Hodgkin's disease patients].

Delbrück H, Weiner S.

Offentl Gesundheitswes. 1985 Nov;47(11):560-4. German. No abstract available.

PMID:
2934654
37.

[Medical risks for tourists and long-distance travelers. Suggestions for prevention].

Delbrück H.

Med Welt. 1983 Aug 26;34(33-34):889-94. German. No abstract available.

PMID:
6633214
38.

[Standardized recall antigen testing in patients with malignant melanoma, endogenous eczema patients and healthy humans].

Stenger D, Delbrück H, Krumrey K, Zaun H.

Z Hautkr. 1983 Mar 1;58(5):293-304. German.

PMID:
6845797
39.

Distribution of the adult lactase phenotypes--lactose absorber and malabsorber--in a group of 131 army recruits.

Cuddenec Y, Delbrück H, Flatz G.

Gastroenterol Clin Biol. 1982 Oct;6(10):776-9. No abstract available.

PMID:
6816656
40.

[Possibilities of treatment of reduction in Hodgkin's disease. III. Can polychemotherapy when combined with radiotherapy of localised stages be reduced? (author's transl)].

Teillet F, Delbrück H, Bayle-Weisgerber C, Asselain B, Lelièvre P, Bernard J.

Dtsch Med Wochenschr. 1981 May 1;106(18):566-70. German.

PMID:
7215184
41.

Malignant bone tumours induced by a local injection of colloidal radioactive 144Cerium in rats as a model for human osteosarcomas.

Allouche M, Delbrück HG, Klein B, Masse R, Matar A, Morin M, Lafuma J, Jasmin C.

Int J Cancer. 1980 Dec 15;26(6):777-82.

PMID:
6938496
42.
43.

Bone tumours induced in rats with radioactive cerium.

Delbrück HG, Allouche M, Jasmin C, Morin M, Deml F, Anghileri L, Masse R, Lafuma J.

Br J Cancer. 1980 May;41(5):809-15.

44.

Effect of calcitonin on metastasis formation by experimental tumors.

Anghileri LJ, Delbrück HG, Cressent M, Desplan C, Talbot JN, Milhaud G.

Arch Geschwulstforsch. 1980;50(2):105-10.

PMID:
7436694
45.

Tumour growth inhibition by calcitonin: role of the age of the animal and the hypocalcemic response.

Anghileri LJ, Delbrück H, Cressent M, Pidoux E.

Arch Geschwulstforsch. 1980;50(7):635-9.

PMID:
7235863
46.

Redistribution of concanavalin A receptors on peripheral blood lymphocytes of myeloma patients.

Wetter O, Delbrůck H, Linder KH, Brandhorst D.

Leuk Res. 1980;4(6):639-50. No abstract available.

PMID:
7206780
47.

Properdin factor B polymorphism in Afghanistan.

Benkmann HG, Goedde HW, Agarwal DP, Flatz G, Rahimi A, Kaifie S, Delbrück H.

Hum Hered. 1980;30(1):39-43.

PMID:
6898201
48.

Divalent cation-phospholipid complexes and tumor growth inhibition.

Anghileri LJ, Delbrück H.

Experientia. 1979 Dec 15;35(12):1664-5.

PMID:
520494
49.

[Possibilities of treatment reduction in Hodgkin's disease (author's transl)].

Teillet F, Delbrück H, Bayle-Weisgerber C, Andrieu JM, Clot P.

Dtsch Med Wochenschr. 1979 Oct 5;104(40):1405-9. German.

PMID:
498955
50.

Supplemental Content

Loading ...
Support Center